medicina53巻4号

2016年04月発行

増刊号 内科診断の道しるべ—その症候、どう診る どう考える

背部・四肢

間欠性跛行

著者： 佐々木誠¹ 小松知広¹ 池脇克則¹

所属機関： ¹防衛医科大学校抗加齢血管内科

ページ範囲：P.380 - P.384

文献概要

チェックリスト
□前屈で症状が改善するか．
□腰痛を伴うか．
□動脈拍動の減弱・消失があるか．
□足関節上腕血圧比（ankle brachial pressure index：ABI）は正常か．
□閉塞性動脈硬化症の場合は全身の他動脈に狭窄はないか．

参考文献

1）Hirsch AT, et al：ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease（lower extremity, renal, mesenteric, and abdominal aortic）；a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines（Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease）. Circulation 113：e463-e465, 2006

2）土田博光，他：間歇性跛行に対する保存療法の評価．脈管学41：327-332, 2001

3）Regensteiner JG, et al：Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease；meta-analysis of six randomized controlled trials. J Am Geriatr Soc 50：1939-1946, 2002

4）Dawson DL, et al：A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med 109：523-530, 2000

5）Matsuo H, Shigematsu H：Effects of the 5-HT2A antagonist sarpogrelate on walking ability in patients with intermittent claudication as measured using the walking impairment questionnaire. Ann Vasc Dis 1：102-110, 2008